IGF, abundantly released in ovulatory follicular fluid, enhances stemness and survival of ovarian cancer cells via activation of the IGF-1R/Akt/mTOR and IGF-1R/Akt/Nanog pathways [180]. This evidence concerns the gene AKT1 and ovarian cancer.